The evolution of population attending youth addiction outpatient clinic (CJC’s) 2014-2015

 

Tend107EN.jpg

Tendances n° 107, OFDT, 4 p.
March 2016

Since 2005, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been responsible for evaluating the youth addiction outpatient clinics (CJC) scheme, an initiative launched in 2004 by the French Ministry of Health, in conjunction with the French Interministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA). This survey reveals the evolution of the population attending the clinics following a public communication campaign conducted by the French National Institute for Prevention and Health Education (INPES) at the start of the year 2015.

This issue of Tendances examines the main findings identified in terms of the methods of entry and the characteristics of the clients accessing the facilities.

Authors : Caroline Protais, Cristina Díaz Gómez, Stanislas Spilka, Ivana Obradovic

Download the PDF file (364 Ko)


Significant trends are:

Firstly, the number of people encouraged to attend by their families is on the rise. This source of referral has contributed to an increase in the proportion of minors and the number of video-game users attending. It appears that this trend can be interpreted as one of the effects of the CJC advertising campaign conducted by the INPES.

Secondly, the proportion of treatment entries related to cannabis, primarily via the judicial channel (the leading recruitment channel for this population for the past ten years) is falling.

Lastly, this survey confirms the difficulties involved in recruiting young people who are heavy alcohol users, as well as women. The share of the latter within the overall population remained stable between 2014 and 2015.

Drugs in Europe


2017 EMCDDA European Drug Report

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

Country drug reports

Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.